Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication.
Wörle
H
H
Maass
E
E
Köhler
B
B
Treuner
J
J
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002547:Cerebral Palsy / Q000139:chemically induced*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins